Skip to main content

bioAffinity Technologies, Inc. (BIAF) Stock Forecast 2025 - AI Price Prediction & Analysis


bioAffinity Technologies, Inc. (BIAF) AI Stock Price Forecast & Investment Analysis

bioAffinity Technologies, Inc. Stock Price Chart and Technical Analysis

Loading bioAffinity Technologies, Inc. interactive price chart and technical analysis...

bioAffinity Technologies, Inc. (BIAF) - Comprehensive Stock Analysis & Investment Research

Deep dive into bioAffinity Technologies, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about bioAffinity Technologies, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For bioAffinity Technologies, Inc.: bioAffinity Technologies, Inc. operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

bioAffinity Technologies, Inc. (Stock Symbol: BIAF) is a leading company in the Industrial Applications and Services sector , specifically operating within the Services-Commercial Physical & Biological Research industry.

The organization employs approximately 1 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing bioAffinity Technologies, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For bioAffinity Technologies, Inc.: With $7M in annual revenue and -2909.8% net margin, the company demonstrates developing profitability.

Annual Revenue: $7 million generating a -2909.8% net profit margin .

Market Capitalization: $7 million - Classified as a small-cap investment offering high growth potential.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for bioAffinity Technologies, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For bioAffinity Technologies, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for bioAffinity Technologies, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: bioAffinity Technologies, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For bioAffinity Technologies, Inc.: Market positioning analysis based on available financial and operational metrics.

bioAffinity Technologies, Inc. strategically competes in the highly dynamic Services-Commercial Physical & Biological Research marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 74.5% gross margin, indicating strong pricing power and operational efficiency.

bioAffinity Technologies, Inc. (BIAF) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for bioAffinity Technologies, Inc. stock analysis.

Loading bioAffinity Technologies, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into bioAffinity Technologies, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if bioAffinity Technologies, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For bioAffinity Technologies, Inc.: With a P/E ratio of -1.10, the market sees the stock as potentially undervalued.

P/E Ratio -1.10x
P/B Ratio 3.65x
Market Cap $7M
EPS $-0.44
Book Value/Share $0.08
Revenue/Share $0.27
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently bioAffinity Technologies, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For bioAffinity Technologies, Inc.:

Gross Margin 74.5%
Operating Margin -2887.7%
Net Margin -2909.8%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess bioAffinity Technologies, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For bioAffinity Technologies, Inc.:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal bioAffinity Technologies, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For bioAffinity Technologies, Inc.:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively bioAffinity Technologies, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For bioAffinity Technologies, Inc.:

Understanding Financial Statement Data

What these metrics mean: Key figures from bioAffinity Technologies, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For bioAffinity Technologies, Inc.: With annual revenue of $7M, bioAffinity Technologies, Inc. represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $7M
R&D Expense $2M
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Shares Outstanding 28M
Growth Metrics (YoY)
EPS Growth -83.5%

Latest bioAffinity Technologies, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting bioAffinity Technologies, Inc. (BIAF) stock price and investment outlook.

bioAffinity Technologies, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of bioAffinity Technologies, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ABSI Unlock Forecast - 30 Days FREE Trial $351M -4.7x 1.8x
BIAF Unlock Forecast - 30 Days FREE Trial $7M -1.1x 3.7x
BIAFW Unlock Forecast - 30 Days FREE Trial $9M x 3.0x
CBIH Unlock Forecast - 30 Days FREE Trial $7M x x
CRL Unlock Forecast - 30 Days FREE Trial $7992M 19.3x 2.4x
FOXO Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
ICLR Unlock Forecast - 30 Days FREE Trial $13555M 13.8x 1.4x
INCY Unlock Forecast - 30 Days FREE Trial $16994M 19.5x 4.1x
IQV Unlock Forecast - 30 Days FREE Trial $33290M 26.9x 5.8x
ISPC Unlock Forecast - 30 Days FREE Trial $3M -2.2x 1.6x
LUNA Unlock Forecast - 30 Days FREE Trial $61M 45.3x 0.7x
MEDP Unlock Forecast - 30 Days FREE Trial $14648M 35.0x 85.0x
MXCT Unlock Forecast - 30 Days FREE Trial $150M -10.6x 0.8x
NOTV Unlock Forecast - 30 Days FREE Trial $56M -1.3x 0.4x
NRC Unlock Forecast - 30 Days FREE Trial $356M 19.8x 16.7x
OABI Unlock Forecast - 30 Days FREE Trial $210M -6.5x 0.8x
OABIW Unlock Forecast - 30 Days FREE Trial $63M x 0.2x
ONMD Unlock Forecast - 30 Days FREE Trial $18M x -1.1x
ONMDW Unlock Forecast - 30 Days FREE Trial $1M x -0.1x

Frequently Asked Questions - bioAffinity Technologies, Inc. Stock Forecast

How accurate are bioAffinity Technologies, Inc. stock predictions?

Our AI model demonstrates 34% historical accuracy for BIAF predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence bioAffinity Technologies, Inc. stock price forecasts?

Our analysis considers bioAffinity Technologies, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is bioAffinity Technologies, Inc. a good investment in 2025?

Based on our AI analysis, bioAffinity Technologies, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are bioAffinity Technologies, Inc. forecasts updated?

bioAffinity Technologies, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced bioAffinity Technologies, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for bioAffinity Technologies, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...